TIF
Inati-Khoriaty, A
Latest News:
- FDA Accelerates Review Of Sickle Cell Disease Medicine Crizanlizumab
- Drones Land in the Cell and Gene Therapy Space
- TIF and the UKTS set up an official thalassaemia training programme for Nepalese nurses
- The Mumbai Hematology Group to host the 8th Thalassemia Lunch-on Symposium in October 2019
- Bluebird puts €1.58m price on gene therapy Zynteglo
